|
Volumn 44, Issue 10, 2000, Pages 2922-2923
|
Potencies of newer fluoroquinolones against viridans group streptococci isolated in 637 cases of bloodstream infection in the SENTRY Antimicrobial Surveillance Program (1997 to 1999): Beyond Canada!
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
CIPROFLOXACIN;
CLINAFLOXACIN;
GATIFLOXACIN;
GREPAFLOXACIN;
LEVOFLOXACIN;
MOXIFLOXACIN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
SPARFLOXACIN;
TROVAFLOXACIN;
ALPHA HEMOLYTIC STREPTOCOCCUS;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
BACTERIAL INFECTION;
BACTERIUM ISOLATE;
GEOGRAPHIC DISTRIBUTION;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
PRIORITY JOURNAL;
STREPTOCOCCUS INFECTION;
ANTI-INFECTIVE AGENTS, FLUOROQUINOLONE;
CANADA;
HUMAN;
STREPTOCOCCAL INFECTIONS;
STREPTOCOCCUS;
|
EID: 0033798024
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.44.10.2922-2923.2000 Document Type: Letter |
Times cited : (12)
|
References (8)
|